Sinovac Biotech Ltd. ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that it has received a notification letter dated January 2, 2026 (the ...

Innovative research into the gene-editing tool targets influenza’s ability to replicate—stopping it in its tracks.

A radiologist and public health expert breaks down what we know about President Trump's CT scan, and what this means for his ...

Knowable Magazine reports 2025 faced turmoil in U.S. science amid job cuts and budget slashes, yet saw advances in gene ...

Sanofi’s Tzield has been accepted for priority review by the U.S. Food and Drug Administration to expand its use to children aged one year and older with stage 2 type 1 diabetes. The submission is ...